Standard BioTools Inc. - Common Stock — Bilan (NASDAQ:LAB)

Afficher le graphique complet Full chart

Financials

Total de l'actif 324.76 M275.21 M390.31 M323.07 M612.34 M567.75 M Total du passif 185.71 M180.62 M160.52 M159.87 M140.62 M143.46 M Total des capitaux propres 139.05 M94.6 M-81.47 M-148.05 M471.72 M424.29 M Total du passif et des capitaux propres 324.76 M275.21 M390.31 M323.07 M612.34 M567.75 M Dette totale 54.22 M61 M64.89 M63.51 M299 K299 K Dette nette -15.31 M32.55 M-101.91 M-51.38 M-292.57 M-187.28 M

Standard BioTools Inc. - Common Stock

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.